Search Results Heading

MBRLSearchResults

mbrl.module.common.modules.added.book.to.shelf
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Are you sure you want to remove the book from the shelf?
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
    Done
    Filters
    Reset
  • Language
      Language
      Clear All
      Language
  • Subject
      Subject
      Clear All
      Subject
  • Item Type
      Item Type
      Clear All
      Item Type
  • Discipline
      Discipline
      Clear All
      Discipline
  • Year
      Year
      Clear All
      From:
      -
      To:
  • More Filters
1 result(s) for "Erythroblasts/cytology/metabolism/pathology"
Sort by:
HSP70 sequestration by free α-globin promotes ineffective erythropoiesis in β-thalassaemia
In human β-thalassaemiaerythroblasts, HSP70 is sequestered in the cytoplasm by the excess of free α-globin chains and can no longer protect the master transcriptional factor of erythropoiesis GATA-1 from caspase-3 cleavage; transduction of a nuclear-targeted HSP70 or a caspase-3 uncleavable GATA-1 mutant restored maturation of erythropoiesis. HSP70 a target in β-thalassemia During normal human erythroid cell maturation, the chaperone protein HSP70 translocates to the nucleus where it protects the master transcriptional factor of erythropoiesis, GATA1, from caspase-3 cleavage. Here Jean-Benoît Arlet et al . show that in erythroblasts from patients with the inherited haemoglobinopathy β-thalassemia major (β-TM), HSP70 is sequestered in the cytoplasm by the excess of free α-globin chains that accumulate in these cells. Transduction of a nuclear-targeted HSP70 mutant or a caspase-3-uncleavable GATA1 mutant restores maturation of β-TM erythroblasts. The discovery of a mechanism contributing to the ineffective erythropoiesis seen in β-TM suggests a rationale for possible targeted therapies for β-TM β-Thalassaemia major (β-TM) is an inherited haemoglobinopathy caused by a quantitative defect in the synthesis of β-globin chains of haemoglobin, leading to the accumulation of free α-globin chains that form toxic aggregates 1 , 2 . Despite extensive knowledge of the molecular defects causing β-TM, little is known of the mechanisms responsible for the ineffective erythropoiesis observed in the condition, which is characterized by accelerated erythroid differentiation, maturation arrest and apoptosis at the polychromatophilic stage 3 , 4 , 5 , 6 . We have previously demonstrated that normal human erythroid maturation requires a transient activation of caspase-3 at the later stages of maturation 7 . Although erythroid transcription factor GATA-1, the master transcriptional factor of erythropoiesis, is a caspase-3 target, it is not cleaved during erythroid differentiation. We have shown that, in human erythroblasts, the chaperone heat shock protein70 (HSP70) is constitutively expressed and, at later stages of maturation, translocates into the nucleus and protects GATA-1 from caspase-3 cleavage 8 . The primary role of this ubiquitous chaperone is to participate in the refolding of proteins denatured by cytoplasmic stress, thus preventing their aggregation 9 . Here we show in vitro that during the maturation of human β-TM erythroblasts, HSP70 interacts directly with free α-globin chains. As a consequence, HSP70 is sequestrated in the cytoplasm and GATA-1 is no longer protected, resulting in end-stage maturation arrest and apoptosis. Transduction of a nuclear-targeted HSP70 mutant or a caspase-3-uncleavable GATA-1 mutant restores terminal maturation of β-TM erythroblasts, which may provide a rationale for new targeted therapies of β-TM.